MarginsXMarginsX
Home › Markets › ECOC

Abvc Biopharma, Inc. (ECOC)

ECOC is quoted over the counter, not listed on an exchange. Abvc Biopharma, Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Last trade · July 15, 2026
$0.0500
No trades since Jul 15, 2026; later closes repeat the last quote
1-year return
-16.0%
Market cap
The company also trades on Nasdaq as ABVC; this OTC line is another class or a foreign line, so its cap is not computed
P/E and P/S
Needs a market cap · Needs a market cap
On trailing twelve months to September 30, 2026 (10-Q)

Closes: Yahoo Finance daily closes, last bar 2026-11-13.

Profile

FieldValue
TickerECOC, quoted over the counter
SEC CIK0001173313
SEC industry codePharmaceutical Preparations
Business addressFremont, CA
Incorporated inNV

Warning signs

Cash runway
0.1 months
$11K cash at September 30, 2026
Share count, 1 year
+11.0%
2025-10-30 to 2026-11-09 · +273.0% over 3 years
Going-concern doubt
Yes
10-Q filed November 10, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These conditions give rise to substantial doubt as to whether the Company will be able to continue as a going concern."
10-Q 2026-11-10
Cash and burn$11K cash; operating cash flow -$541K a quarter.Report 2026-09-30
Shares outstanding26,976,625 (2026-11-09); 24,301,089 a year earlier; 7,231,940 three years earlier.Cover page 2026-11-09
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorSimon & Edward, LLP, Rowland Heights, California, United States; changed auditors 2 times in 24 months8-K 4.01 2026-07-02
Late filings, 12 months1 NT noticeNT 10-Q 2026-05-15
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
Not filed$1.1M-$439K$11K$30KNeeds four quarters10-Q 2026-11-10
Q2 2026
2026-06-30
Not filed-$737K-$244K$32K$59KNeeds four quarters10-Q 2026-08-12
Q1 2026
2026-03-31
Not filed-$1.6M-$894K$140K$89KNeeds four quarters10-Q 2026-05-18
Q4 2025
2025-12-31
-$500K-$2.8M-$588K$681K$756K$296K10-K 2026-03-03
Q3 2025
2025-09-30
$796K-$2.0M-$965K$192K$1.3MNeeds four quarters10-Q 2025-11-03
Q2 2025
2025-06-30
Not filed-$2.3M-$894K$388K$1.1MNeeds four quarters10-Q 2026-08-12
Q1 2025
2025-03-31
Not filed-$842K-$540K$152K$810KNeeds four quarters10-Q 2026-05-18
Q4 2024
2024-12-31
$2K-$732K-$702K$248K$1.8M$510K10-K 2026-03-03

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B42026-11-13
Latest annual report10-K2026-03-03
Latest quarterly / interim10-Q2026-11-10
Latest current report8-K2026-11-02
Latest proxyDEF 14A2026-09-29

Source: SEC EDGAR submissions feed, 803 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier